Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 12:54 PM UTC
| NCT Number | NCT06095505 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Puma Biotechnology, Inc. |
| Last Updated on CT.gov | August 17, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT06095505 is currently recruiting participants. This phase2 study for small cell lung cancer is actively seeking new participants at 30 locations across the United States. The study is sponsored by Puma Biotechnology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06095505 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06095505 was last updated 2 weeks ago (August 17, 2026). HelloStudys verifies this status automatically.